Literature DB >> 34907117

Patho-Mechanisms for Hemorrhage/Sepsis-Induced Indirect Acute Respiratory Distress Syndrome: A Role for Lung TIE1 and Its Regulation by Neutrophils.

Jiali Zhu1,2, Jinbao Li1, Chun-Shiang Chung2, Joanne L Lomas-Neira2, Alfred Ayala2.   

Abstract

INTRODUCTION: Severe hemorrhage (Hem) has been shown to be causal for the development of extra-pulmonary/indirect acute respiratory distress syndrome (iARDS) and is associated with severe endothelial cell (EC) injury. EC growth factors, Angiopoietin (Ang)-1 and -2, maintain vascular homeostasis via tightly regulated competitive interaction with the tyrosine kinase receptor, Tie2, expressed on ECs.
OBJECTIVE: Since it has been reported that the orphan receptor, Tie1, may be able to play a role in Ang:Tie2 signaling; we chose to examine Tie1's capacity to alter the lung Ang:Tie2 interaction in response to the sequential insults of shock/sepsis (cecal ligation and puncture [CLP]), culminating in iARDS.
METHODS: Male mice were subjected to Hem alone or sequential Hem followed 24 hours later by CLP that induces iARDS. Changes in lung and/or plasma levels of Tie1, Tie2, Ang-1, Ang-2, various systemic cytokine/chemokines and indices of lung injury/inflammation were then determined. The role of Tie1 was established by intravenous administration of Tie1 specific or control siRNA at 1 h post-Hem. Alternatively, the contribution of neutrophils was assessed by pre-treating mice with anti-neutrophil antibody depletion 48 h prior to Hem.
RESULTS: Lung tissue levels of Tie1 expression elevated over the first 6 to 24 h post-Hem alone. Subsequently, we found that treatment of Hem/CLP mice with Tie1-specific siRNA not only decreased Tie1 expression in lung tissue compared to control siRNA, but, suppressed the rise in lung inflammatory cytokines, lung MPO and the rise in lung protein leak. Finally, much as we have previously shown that neutrophil interaction with resident pulmonary vascular ECs contribute significantly to Ang-2 release and EC dysfunction, central to the development of iARDS. Here, we report that depletion of neutrophils also decreased lung tissue Tie1 expression and increased Tie2 activation in Hem/CLP mice.
CONCLUSION: Together, these data imply that shock-induced increased expression of Tie1 can contribute to EC activation by inhibiting Ang:Tie2 interaction, culminating in EC dysfunction and the development of iARDS.
Copyright © 2021 by the Shock Society.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34907117      PMCID: PMC8916968          DOI: 10.1097/SHK.0000000000001902

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  45 in total

1.  Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge.

Authors:  Joanne Lomas-Neira; Chun-Shiang Chung; Mario Perl; Stephen Gregory; Walter Biffl; Alfred Ayala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-09-09       Impact factor: 5.464

2.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Authors:  P C Maisonpierre; C Suri; P F Jones; S Bartunkova; S J Wiegand; C Radziejewski; D Compton; J McClain; T H Aldrich; N Papadopoulos; T J Daly; S Davis; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males.

Authors:  R Zellweger; M W Wichmann; A Ayala; S Stein; C M DeMaso; I H Chaudry
Journal:  Crit Care Med       Date:  1997-01       Impact factor: 7.598

4.  Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice.

Authors:  Joanne L Lomas; Chun-Shiang Chung; Patricia S Grutkoski; Brian W LeBlanc; Liz Lavigne; Jonathan Reichner; Stephen H Gregory; Lesley A Doughty; William G Cioffi; Alfred Ayala
Journal:  Shock       Date:  2003-04       Impact factor: 3.454

5.  Blood clotting and traumatic injury with shock mediates complement-dependent neutrophil priming for extracellular ROS, ROS-dependent organ injury and coagulopathy.

Authors:  C D Barrett; A T Hsu; C D Ellson; B Y Miyazawa; Y-W Kong; J D Greenwood; S Dhara; M D Neal; J L Sperry; M S Park; M J Cohen; B S Zuckerbraun; M B Yaffe
Journal:  Clin Exp Immunol       Date:  2018-09-09       Impact factor: 4.330

6.  Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.

Authors:  K Teichert-Kuliszewska; P C Maisonpierre; N Jones; A I Campbell; Z Master; M P Bendeck; K Alitalo; D J Dumont; G D Yancopoulos; D J Stewart
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

7.  Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.

Authors:  Tom C M Seegar; Becca Eller; Dorothea Tzvetkova-Robev; Momchil V Kolev; Scott C Henderson; Dimitar B Nikolov; William A Barton
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

8.  The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor.

Authors:  M J McCarthy; M Crowther; P R Bell; N P Brindle
Journal:  FEBS Lett       Date:  1998-02-27       Impact factor: 4.124

9.  Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.

Authors:  Ulrike Fiedler; Yvonne Reiss; Marion Scharpfenecker; Verena Grunow; Stefanie Koidl; Gavin Thurston; Nicholas W Gale; Martin Witzenrath; Simone Rosseau; Norbert Suttorp; Astrid Sobke; Matthias Herrmann; Klaus T Preissner; Peter Vajkoczy; Hellmut G Augustin
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

10.  Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.

Authors:  Samir M Parikh; Tadanori Mammoto; Aylit Schultz; Hai-Tao Yuan; David Christiani; S Ananth Karumanchi; Vikas P Sukhatme
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.